Bioequivalence of Famcivir Tablet to FamvirTM Tablet 250 mg (Famciclovir 250 mg)
![]() |
Kang, Hyun-Ah
(Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital)
Cho, Hea-Young (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) Oh, In-Joon (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) Lee, Myung-Hee (Kwangju Christian Hospital) Lee, Yong-Bok (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital) |
1 |
Y.Y. Lee, S.K. Joung, T.S. Cho, Y.R. Lee, K.R. Lee and H.J. Lee, Bioequivalence of |
2 | 식품의약품안전청 고시 제 2002-60호, 생물학적동등성시험기준 (2002. 11. 22) |
3 | 식품의약품안전청 고시 제 1999-67호, 의약품임상시험관리기준 (2000. 1. 4) |
4 | J.R. McMeekin, S.E. Fowles, C.F. Winton and D.M. Pierce, Rapid high-performance liquid chromatographic method for the analysis of the active antiherpes agent, penciclovir and its precursor, BRL 42359, in human plasma and urine following administration of the oral prodrug, famciclovir, Analytical Proceedings, 29, 178-180 (1992) |
5 | A. Loregian, R. Gatti, G. Palu and E.F. De Palo, separation methods for acyclovir and related antiviral compounds, J. Chromatography B, 764, 289-311 (2001) DOI ScienceOn |
6 |
Statistical Solutions Ltd., Equiv |
7 | W.S. Choi, G.J. Im, D.K. Kim, T.K. Kim, I. Jung, T.S. Kim, S.J. Lee, N. Lee, Y.W. Kim, J.S. Kim and K Chang, pharmacokinetic studies of 2-amino-9-(3-acetoxymethyl-4-isopropoxycarbonyl-oxybut-1-yl)purine, an oral prodrug for the antiviral agent penciclovir, Drug Metab. Dispos., 29(7), 945-949 (2001) |
8 | S.C. Bioke, M.Pue, P.R. Audet, M.I. Freed, R.E. Ilson and D.K. Jorkasky, Pharmacokinetics of famciclovir in subjects with chronic hepatic disease, J. Clin, Pharmacol., 34, 1199-1207 (1994) DOI ScienceOn |
9 | K.S. Gill and M.J. Wood, The clinical pharmacokinetics of famciclovir, Clin. Pharmacokinet., 31(1), 1-8 (1996) DOI ScienceOn |
10 | D.K. Kim, N. Lee, D.H. Ryu, Y.W. Kim, J.S. Kim. K. Chang, G.J. Im, W.S. Choi, Y.B. Cho, K.H. Kim, D. Colledge, S. Locarnini, Synthesis and evaluation of 2amino-9-(3-acyloxymethyl-4-alkoxycarbony loxybut-1-yl)purines and 2-amino-9-(3-alkoxycarbonyloxymethyl-4-alkoxycarbonyloxybut-1-yl)purines as potential prodrugs of penciclovir, Bioo. Med Chem., 7, 1715-1725 (1999) DOI ScienceOn |
![]() |